Evidence map›Paper›PMID 42598155›Full record

ArticleJournal of orthopaedic case reports2026

Double-Layered Antibiotic-Loaded Cement Spacer for Hip Infection: A Report of Two Cases.

Akira Yuasa, Hiroki Kobayashi

Abstract readCase Reports
In one paragraph

Article in Journal of orthopaedic case reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Akira YuasaDepartment of Orthopedic Surgery, Japan Self-Defense Forces Central Hospital, Tokyo, Japan.
Hiroki KobayashiDepartment of Orthopedic Surgery, National Defense Medical College, Tokorozawa, Japan.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Introduction: Septic arthritis of the hip and periprosthetic joint infection (PJI) are serious conditions that can cause joint destruction and severe functional impairment. In cases with advanced joint destruction or implant-related infection, two-stage reconstruction using an antibiotic-loaded cement spacer is widely performed. However, conventional polymethylmethacrylate (PMMA) spacers have limitations, including a short duration of antibiotic release and potential antibiotic inactivation caused by polymerization heat. A double-layered antibiotic-loaded cement spacer consisting of an antibiotic-loaded calcium phosphate paste core covered with PMMA cement has been developed to combine sustained antibiotic release with mechanical stability. Case Report: We report two infected hip cases treated using this novel spacer: One patient with PJI following hemiarthroplasty and one patient with septic arthritis of the hip. In both patients, extensive debridement and implantation of a double-layered antibiotic-loaded cement spacer were performed as the first stage of treatment. Inflammatory markers improved promptly after surgery, and no mechanical complications, including spacer fracture or dislocation, occurred during the interval period. Second-stage total hip arthroplasty was successfully performed in both cases. At the final follow-up, both patients were ambulatory without evidence of recurrent infection. Conclusion: A double-layered antibiotic-loaded cement spacer may provide both effective infection control and mechanical stability during two-stage reconstruction for hip infections. This technique may represent a useful treatment option for the management of septic arthritis of the hip and PJI.

Indexed as

calcium phosphateDouble-layered antibiotic-loaded cement spacerdrug delivery systemperiprosthetic joint infectionseptic arthritis of the hip

Identifiers

PMID42598155
PMCPMC13470441

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.